Dyne Therapeutics prices public offering of 24.24 million shares at $8.25 per share

From Nasdaq: 2025-06-30 21:59:00

Dyne Therapeutics Inc. (DYN) has priced its public offering of 24.24 million shares of common stock at $8.25 per share, expecting gross proceeds of $200.0 million. The offering is set to close on or about July 2, 2025, with an option for underwriters to purchase an additional 3.64 million shares. Morgan Stanley, Jefferies, Stifel, and Guggenheim Securities are serving as joint book-running managers, with Jones as co-manager for the offering.



Read more at Nasdaq: Dyne Therapeutics Prices Public Offering Of About 24.24 Mln Shares At $8.25/shr